MedTrace Logo

High Volume Plasma Exchange in Children With Acute Liver Failure and Acute on Chronic Liver Failure

NCT02719210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2018-12-06

No results posted yet for this study

Summary

All the children with acute liver failure who are candidates for transplant but have constraints for transplant will be randomized either to receive standard medical therapy or high volume plasma exchange along with standard medical therapy with the aim to assess the effect of high volume plasma exchange on transplant free survival.

Conditions

  • Acute Liver Failure

Interventions

BIOLOGICAL

High Volume Plasma Exchange

DRUG

Hypertonic 3% saline

DRUG

Mannitol

DEVICE

Elective positive pressure ventilation

Sponsors & Collaborators

  • Institute of Liver and Biliary Sciences, India

    lead OTHER

Principal Investigators

  • Dr Arti Pawaria, MD · Institute of Liver and Biliary Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02719210 on ClinicalTrials.gov